Axsome Therapeutics, Inc. (AXSM)
199.02
-7.25
(-3.51%)
USD |
NASDAQ |
Aug 28, 16:00
199.30
+0.28
(+0.14%)
After-Hours: 20:00
Axsome Therapeutics Free Cash Flow : -71.96M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -71.96M |
| March 31, 2026 | -70.99M |
| December 31, 2025 | -93.88M |
| September 30, 2025 | -101.39M |
| June 30, 2025 | -121.10M |
| March 31, 2025 | -118.83M |
| December 31, 2024 | -128.68M |
| September 30, 2024 | -132.82M |
| June 30, 2024 | -168.02M |
| March 31, 2024 | -193.34M |
| December 31, 2023 | -145.66M |
| September 30, 2023 | -143.04M |
| June 30, 2023 | -111.94M |
| March 31, 2023 | -90.24M |
| December 31, 2022 | -117.21M |
| September 30, 2022 | -118.62M |
| June 30, 2022 | -122.83M |
| March 31, 2022 | -114.46M |
| December 31, 2021 | -108.84M |
| September 30, 2021 | -100.27M |
| Date | Value |
|---|---|
| June 30, 2021 | -88.98M |
| March 31, 2021 | -82.47M |
| December 31, 2020 | -78.50M |
| September 30, 2020 | -75.50M |
| June 30, 2020 | -70.38M |
| March 31, 2020 | -60.17M |
| December 31, 2019 | -46.39M |
| September 30, 2019 | -38.62M |
| June 30, 2019 | -33.91M |
| March 31, 2019 | -32.89M |
| December 31, 2018 | -30.09M |
| September 30, 2018 | -26.58M |
| June 30, 2018 | -27.11M |
| March 31, 2018 | -26.54M |
| December 31, 2017 | -26.48M |
| September 30, 2017 | -27.41M |
| June 30, 2017 | -25.84M |
| March 31, 2017 | -24.07M |
| December 31, 2016 | -21.39M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Eli Lilly & Co. | 13.56B |
| Liquidia Corp. | 150.69M |
| Filana Therapeutics, Inc. | -29.30M |
| CorMedix, Inc. | 250.11M |
| Eloxx Pharmaceuticals, Inc. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.95M |
| Cash from Investing (Quarterly) | -0.45M |
| Cash from Financing (Quarterly) | 48.15M |
| Free Cash Flow Per Share (Quarterly) | -0.6448 |
| Free Cash Flow to Equity (Quarterly) | -38.20M |
| Free Cash Flow to Firm (Quarterly) | -30.19M |
| Free Cash Flow Yield | -0.71% |